Treatment of Leishmaniasis
Leishmaniasis is caused by Leishmania protozoa transmitted by sandfly bites, presenting in visceral, cutaneous, or mucocutaneous forms. Visceral leishmaniasis (kala-azar) causes fever, splenomegaly, and pancytopaenia. Amphotericin B and miltefosine are first-line treatments.
Leishmaniasis is caused by Leishmania protozoa transmitted by sandfly bites, presenting in visceral, cutaneous, or mucocutaneous forms. Visceral leishmaniasis (kala-azar) causes fever, splenomegaly, and pancytopaenia. Amphotericin B and miltefosine are first-line treatments.
First-Line Treatment Principles
- ✓Identify pathogen and antimicrobial sensitivities before initiating targeted therapy
- ✓De-escalate antimicrobial spectrum as soon as culture/sensitivity results available
- ✓Source control: drainage of abscesses, removal of infected catheters/prosthetics
- ✓Empirical antibiotics: cover likely pathogens based on clinical syndrome and local resistance patterns
- ✓Adhere to minimum effective duration to reduce resistance selection
Medications Used in Leishmaniasis
Amphotericin B is an antifungal agent used to treat fungal infections of the skin, nails, mucous membranes, or systemic organs.
Miltefosine is an oral antiprotozoal agent and the first oral treatment for visceral leishmaniasis, also used for cutaneous and mucosal forms of the disease.
Non-Pharmacological Management
- •Infection prevention: hand hygiene, vaccination, insect bite prevention (malaria/dengue/Lyme)
- •Isolation precautions for highly contagious or drug-resistant organisms
- •Nutritional support: adequate protein and calorie intake during infectious illness
- •Rest and adequate hydration during acute illness
- •Vector control for vector-borne diseases (mosquito nets, repellents, chemoprophylaxis for travel)
- •Contact tracing for notifiable diseases (TB, meningococcal, sexual infections)
Treatment Goals
Monitoring Parameters
- ◆Temperature, heart rate, respiratory rate, and blood pressure: 4-hourly in hospital
- ◆CRP, procalcitonin: inflammation markers to guide treatment response and de-escalation
- ◆Blood cultures: before antibiotics if systemic infection suspected; repeat if deterioration
- ◆Organ function: LFTs, renal function, FBC — especially with prolonged therapy
- ◆Antimicrobial drug levels (vancomycin, aminoglycosides) to optimise dosing and prevent toxicity
- ◆Clinical response at 48–72h: reassess empirical therapy if no improvement
Escalation Criteria
- →Sepsis/septic shock: immediate IV broad-spectrum antibiotics within 1 hour; ICU admission
- →Clinical deterioration at 48–72h despite appropriate antibiotics → reassess diagnosis, obtain cultures, consider resistant organisms
- →Drug-resistant organism identified → infectious disease specialist review
- →Immunocompromised host: lower threshold for escalation; consider uncommon pathogens (fungal, mycobacterial)
Special Populations
Clinical Insights
Not sure about your symptoms?
Our AI Symptom Checker analyses your symptoms and suggests the most likely diagnoses — including relevant treatment pathways.
Use AI Symptom Checker →